Select Page

Innovations in Non-Invasive Stone Treatment

Each year, more than three million Americans see a physician for kidney stones and over 700,000 procedures are performed to break large kidney stones.

SonoMotion is developing non-invasive solutions for kidney stone disease with two breakthrough products:

Break Wave™

Break Wave will fragment large kidney stones faster, safer and more effectively than existing options..

Stone Clear™

Stone Clear will help clear residue fragments within 15 minutes in an office setting without anesthesia. 

Latest News

May 13-15th, 2022

Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).

May 5th, 2022

First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video) .

April, 6th, 2022

SonoMotion completes initial close of $11.5 Million Series-C funding round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.

March 22nd, 2022

Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL.  Article selected for the cover of the May edition (press release)

January 24th, 2022

SonoMotion treats its 40th subject in the Break Wave Feasibility First-In-Human clinical trial.

October 1st, 2021

SonoMotion secures a $400,000 Commercial Readiness Program (CRP) SBIR grant from the NIH.

November 7th, 2019

SonoMotion closes $10M Series-B round co-led by Advance MedTech Holdings Pte. Ltd., MedVenture Partners Inc and BioVentures. Link to press release.

August 20th, 2019

SonoMotion initiates First-In-Human clinical trial of its Break WaveTM stone fragmentation system

May 1st, 2019

SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break WaveTM First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.

March 28th, 2019

GE Healthcare and SonoMotion sign a second co-development agreement and expand their strategic relationship with an updated OEM agreement.

Management Team

Oren Levy, PhD

Chief Executive Officer

Dr. Oren Levy is an experienced medical device leader and entrepreneur with an outstanding record of achievement. Dr. Levy played a key role in the management and acquisition of Fluid Medical, an ultrasound based medical device startup, by Volcano Corporation (acquired by Philips). Dr. Levy has led and managed multi-disciplinary teams including disposable, hardware and software R&D and product marketing in both large-company and entrepreneurial environments. Dr. Levy integrates a personal background in science, operations and management consulting to introduce structure and rigor to a start-up environment. Most recently, Dr. Levy led Volcano Corporation’s Mountain View office with $3.4M annual budget supervising an eleven person team developing a percutaneous forward looking intra‐cardiac ultrasound imaging device. Dr. Levy received a PhD in Biophysics and a double BA degree in Physics and Astrophysics from UC Berkeley.

Doug Corl, PhD

Chief Technology Officer

Dr. Corl is a proven and recognized ultrasound expert with over 35 years of experience in developing and delivering commercial ultrasound-based medical devices. Dr. Corl has 38 issued patents and was either the CTO or Chief Scientist for the past 24 years at both early stage startups and large multinational ultrasound-based companies, including Volcano Corporation, Keimar, PharmaSonics and Cardiometrics. Dr. Corl received a PhD in Electrical Engineering from Stanford University and a BA and MS in Electrical Engineering from UC Irvine.

Physician Advisors

Dr. James Lingeman, MD

Indiana University

Professor of Urology and past President of the Endourological Society

Dr. Mathew Sorensen, MD, MS

University of Washington and Puget Sound VA Hospital

Associate Professor of Urology and Director of the Comprehensive Metabolic Stone Clinic

Dr. Brian Eisner, MD

Harvard Medical School - Assistant Professor of Surgery

MassGeneral – Co-Director, Kidney Stone Program

Dr. Ben Chew, MD

University of British Columbia - Associate Prof. of Urology

Vancouver General Hospital – Director of Clinical Research at the Stone Centre

Technical Advisors

Michael Bailey, PhD

University of Washington, Seattle

Faculty in Mechanical Engineering and Urology,

Senior Principal Engineer at the Applied Physics Lab and Program Director of NIH Program Projecton Lithotripsy

 

Barbrina Dunmire, MS

University of Washington, Seattle

Sr. Biomedical Engineer at Applied Physics Lab

Bryan Cunitz, MS

University of Washington, Seattle

Sr. Electrical Engineer at the Applied Physics Lab

Adam Maxwell, PhD

University of Washington, Seattle

Research Assistant Professor of Urology

Publications

Fragmentation of stones by Burst Wave Lithotripsy in the first 19 humans
Harper JD, Lingeman JE, Sweet RM, Metzler IS, Sunaryo PL, Williams JC Jr, Maxwell AD, Thiel J, Cunitz BW, Dunmire B, Bailey MR, Sorensen MD. J Urol. 2022 May;207(5):1067-1076.

Recent Advances in the Science of Burst Wave Lithotripsy and Ultrasonic Propulsion
D Raskolnikov, Bailey MR, Harper JD.    BME Frontiers Volume 2022. Article ID 9847952

Fragmentation of Urinary Calculi In Vitro by Burst Wave Lithotripsy
Maxwell AD, Cunitz BW, Kreider W, Sapozhnikov O, Hsi RS, Harper JD, Bailey MR, Sorensen MD. J Urol. 2015 Jan;193(1):338-44

Bursting through limitations of SWL
Thoma C. Nat Rev Urol. 2014 Oct;11(10):540

Combined Burst Wave Lithotripsy and Ultrasonic Propulsion for Improved Urinary Stone Fragmentation
Zwaschka TA, Ahn JS, Cunitz BW, Bailey MR, Dunmire B, Sorensen MD, Harper JD, Maxwell AD. J Endourol. 2018 Apr;32(4):344-349

Detection and Evaluation of Renal Injury in Burst Wave Lithotripsy Using Ultrasound and Magnetic Resonance Imaging
May PC, Kreider W, Maxwell AD, Wang YN, Cunitz BW, Blomgren PM, Johnson CD, Park JSH, Bailey MR, Lee D, Harper JD, Sorensen MD. J Endourol. 2017 Aug;31(8):786-792

First-in-human feasibility trial for ultrasonic propulsion of kidney stones
Harper JD, Cunitz BW, Dunmire B, Lee FC, Sorensen MD, Hsi RS, Thiel J, Wessells H, Lingeman JE, Bailey MR. J Urol. 2016 Apr;195(4):956-964

Ultrasonic propulsion of kidney stones – Review
May PC, Bailey MR, Harper JD. Curr Opin Urol. 2016 May;26(3):264-70

Preclinical safety and effectiveness studies of ultrasonic propulsion of kidney stones
Harper JD, Dunmire B, Wang YN, Simon JC, Liggitt D, Paun M, Cunitz BW, Starr F, Bailey MR, Penniston KL, Lee FC, Hsi RS, Sorensen MD. Urology. 2014 Aug;84(2):484-9

Use of the acoustic shadow width to determine kidney stone size with ultrasound
Dunmire B, Harper JD, Cunitz BW, Lee FC, Hsi R, Liu Z, Bailey MR, Sorensen MD. J Urol. 2016 Jan;195(1):171-7

Improved detection of kidney stones using an optimized Doppler imaging sequence
Cunitz B, Dunmire B, Paun M, Sapozhnikov O, Kucewicz J, Hsi R, Lee F, Sorensen M, Harper J, Bailey M. IEEE Int Ultrason Symp. 2014 Sep 3;2014:452-455

Contact Us

1600 West Hillsdale Boulevard, Suite 105 San Mateo, CA 94402

Dr. Oren Levy, CEO

info@sonomotion.com